Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 May 2022 for Intersect ENT, Inc., €1.1M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Patrick A. Broderick: trading record in brief
Patrick A. Broderick, listed as board member, appears in our data through filings on Intersect ENT, Inc. shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 1 December 2021 to 13 May 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 May 2022: a transaction of €1.1M, in Intersect ENT, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Patrick A. Broderick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
41,999 shares@ US$28.2594.3% of flowCommon StockSEC:0001562180-22-004074:0
25,895 shares0Common StockSEC:0001562180-22-001098:0
2,935 shares@ US$26.90725.7% of flowCommon StockSEC:0001562180-21-007463:0
3 of 3 declarations
